What are the Chinese medicine stocks?

What are the stocks of traditional Chinese medicine

The stocks of traditional Chinese medicine are: Yunnan Baiyao, Pientzehuang, Baiyunshan, Tongrentang, Haiwang Biologicals, Fengyuan Pharmaceuticals, Dong'a Gum, Lizhu Group and so on.

(1) Yunnan Baiyao: it is a company mainly dealing with chemical raw materials, chemical pharmaceutical preparations, proprietary Chinese medicines, Chinese herbal medicines, biological products, etc., and its circulating market capitalization is ranked first in the industry, which is 82.197 billion yuan, and its price-earnings ratio reaches 24.28;

(2) Pientzehuang: a leading traditional Chinese medicine, the quarterly report of Pientzehuang for the second quarter of 2021 shows that the total operating income year-on-year increased by 20.57% to 1.847 billion yuan, and net profit increased by 38.54% year-on-year to 550 million yuan. Leading in the field of traditional Chinese medicine, Pientzehuang prescription belongs to the state-level top secret formula and is one of the few medicines allowed to use natural musk. The core products of the company are Pientzehuang series, including Pientzehuang, Pientzehuang capsule, compound Pientzehuang ointment and compound Pientzehuang tablets. Actively building up the strategic pattern of "one core and multiple products" in pharmaceutical manufacturing, the subsidiary Pientzehuang Cosmetics has already owned several brands, such as "Pientzehuang", "Queen" and so on.

(3) Baiyunshan: a leading traditional Chinese medicine company, the second quarter of 2021 shows that the company's operating income increased by 19.26% year-on-year to 16.08 billion yuan, and net profit increased by 50.75% year-on-year to 875 million yuan. After years of meticulous construction and accelerated development, the Group has gradually formed four major business segments, namely "Great Southern Medicine", "Great Health", "Great Business" and "Great Medical". The company has gradually formed four major business segments, namely "Great Southern Medicine", "Great Health", "Great Commerce" and "Great Medical", as well as three new business modes, namely "e-commerce", "capital and finance" and "medical equipment".

(4) Tongrentang: a leading traditional Chinese medicine company, Tongrentang's total revenue in Q2 2021 increased 22.84% year-on-year to 3.653 billion yuan, and net profit increased 26.61% year-on-year to 306 million yuan. The parent company has more than 500 product approval numbers, with more than 200 year-round production varieties, covering 28 product dosage forms such as pills, bulk, wine and capsules, oral liquids, and dropping pills, with the original powder preparation as the core, forming the cardiovascular and cerebral vascular series represented by Angong Niuhuang Pills, Tongren Niuhuang Qingxin Pills, and Tongren Dawuoluowan; the gynecological series represented by Tongren Wuqi Baifeng Pills and Kunbao Pills, and the Guogong Wine, Bone Spurs Pain Relieving Liquid as the representative of the liquor series, such as twelve different series of varieties group.

(5) Haiwang Bio: the company's production of about 500 kinds of products, divided into four categories of chemical drugs, traditional Chinese medicine, health food and biological drugs, has been formed to anti-tumor products as the leading, covering the cardio-cerebral vascular, respiratory, digestive and other 11 categories of varieties of product system (April 8, 2013, the company said the company does not produce influenza vaccine products, and there is no R & D). H7N9 avian influenza-related vaccine products.

(6) Fengyuan Pharmaceuticals: the company is the first domestic production of hypertension drug cilnidipine high-tech enterprises, and has a number of national first and second class new drug varieties of independent intellectual property rights of the product, through the national double-high certification. Main biological drugs, traditional Chinese medicine, chemical synthetic drugs and their preparations.

(7) Dong'a Gum: the company's main business is the traditional Chinese medicine industry, is the country's largest gum production enterprise.

(8) Liju Group: Ginseng Astragalus Fuzheng Injection is the company's exclusive variety, which belongs to the protected varieties of traditional Chinese medicine and is included in the national health insurance catalog.

Chinese medicine leading stocks which:1 Pientzehuang; 2 Yunnan Baiyao; 3 Jiuzhitang; 4 Tongrentang; 5 Baiyunshan; 6 Jiangzhong Pharmaceutical; 7 Ma Yinglong. In addition, traditional Chinese medicine stocks are: Haiwang Biological, Fengyuan Pharmaceuticals, Dong'a Agaricus, Lizhu Group and so on. From the second half of last year, "the fifth batch of medicine collection" policy to carry out since the CSI pharmaceutical index has continued to retrace more than 20%, nearly a year within the dimensions of the decline -14%, while the CSI Chinese medicine index is "a standout", nearly a year or so up as much as nearly 40%, ranking first in the pharmaceutical sector. Ranked first in the pharmaceutical sub-sector. 1, Tongrentang (600085): leading stocks of traditional Chinese medicine. October 22 news, Tongrentang as of 15:00, the stock rose 0.61%, at 33.11 yuan; 5 days within the share price fell 1.06%, the market value of 45.409 billion yuan.

The company has been listed for more than 10 years of growth and development, has formed to the core of the manufacturing of proprietary Chinese medicines, with the planting of Chinese herbal medicines, research and development of proprietary Chinese medicines, pharmaceutical logistics and distribution, pharmaceutical retailing of a more complete industrial chain.

2, Baiyunshan (600332): leading stocks of traditional Chinese medicine. October 22 news, Baiyunshan shares fell 0.5% in 5 days, up 1.71% this year, the latest 29.8 yuan, the price-earnings ratio of 16.62.

The company is the domestic traditional Chinese medicine industry with the most varieties of the most complete, the largest number of Chinese old brands, the largest output value of traditional Chinese medicine enterprises, the variety of traditional Chinese medicines as many as There are more than 400 kinds of traditional Chinese medicines, covering almost all traditional Chinese medicine classifications, 45 kinds of national Chinese medicine secondary protection varieties, of which more than 20 are exclusive production varieties, and there are more than 100 kinds of foreign brand-name pharmaceutical products exclusively represented by the company. Such as Wang Lao Ji, Chen Li Ji, Pan Gao Shou, Jing Xiu Tang, etc., all of which are long-established century-old stores. These include 20 exclusive products such as Quenching Thirst Pills and Hua Tuo Zaizao Pills. Wanglaoji Herbal Tea, Baoji Pills, Wu Ji Bai Feng Pills and other products are well-known in South China and Southeast Asia. After five enterprises of the company, including Wanglaoji Pharmaceuticals and Jingxiutang Pharmaceuticals, were selected as the first batch of "old Chinese brands", three enterprises, including Zhongyi Pharmaceuticals, were selected as the second batch of "old Chinese brands".

3, Pientzehuang (600436): leading stock of traditional Chinese medicine. on October 22, opening news, Pientzehuang latest reported 434.99 yuan, volume of 30,100,000 lots, total market value of 262.437 billion yuan.

The company was awarded the title of "high-tech enterprise" by the Ministry of Science and Technology of China, and passed the re-recognition of high-tech enterprise, and was evaluated as "Top 10 Chinese Traditional Chinese Medicine Enterprises in Scientific and Technological Innovation Output in 2015".

The other traditional Chinese medicine conceptual stocks are as follows: Tianyin Pharmaceuticals, JiuDian Pharmaceuticals, Erkang Pharmaceuticals, Qian Qian Pharmaceuticals. The company's main business is the development of a new product line, which will be launched in the next few years.